Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s New Criminal Investigations Chief Wants Global Reach

Executive Summary

Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in interview with “The Pink Sheet.”

You may also be interested in...



FDA Posts Investigator In Singapore, But Trims Foreign Office List

FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA is shifting from a predominantly domestic focus to global as drug criminal organizations spread worldwide,

FDA Posts Investigator In Singapore, But Trims Foreign Office List

FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally

FDA Posts OCI Agent In Singapore, But Other Foreign Offices Close

China offices consolidate to allow FDA to 'strategically focus its resources.'

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS056734

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel